Todisco Tommaso, Baglioni Stefano, Eslami Amir, Scoscia Elvio, Todisco Cristina, Bruni Lucio, Dottorini Maurizio
Pulmonary Division and Respiratory ICU, R. Silvestrini Hospital, Perugia.
Chest. 2004 Jun;125(6):2217-23. doi: 10.1378/chest.125.6.2217.
Acute respiratory failure (ARF) can be treated with either invasive mechanical ventilation (IMV) or noninvasive mechanical ventilation (NIMV), which can spare the complications of artificial airways. To evaluate the efficacy of an integrated approach using negative pressure ventilation (NPV) with iron lung and noninvasive positive pressure ventilation (NPPV), we performed a prospective study in a group of patients admitted to our respiratory ICU (RICU) for ARF due to exacerbation of chronic respiratory failure (CRF).
RICU at "R. Silvestrini" Hospital in Perugia, Italy.
One hundred fifty-two consecutive patients were included in the study and treated with iron lung as first choice or, when contraindicated or not tolerated, with NPPV using a nasal or facial mask. After 2 h of noninvasive mechanical ventilation (NIMV), the patients were reevaluated; in case of clinical deterioration, patients receiving NPV were switched to NPPV. When NPPV as a first or second line of treatment failed the patients were intubated.
One hundred fifty-two patients received NIMV, 97 with iron lung as the first choice of treatment, and 55 with NPPV. Six patients treated with NPV were switched to NPPV during the first 2 h of treatment. Twenty-five patients required IMV. The success rate of the integrated use of NIMV (NPV plus NPPV) was 81.6%, compared to that of NPV (83.5%) and NPPV (70.5%). Twenty-one patients (13.8%) required tracheostomy; the duration of hospital stay was significantly lower in patients treated with NIMV only. Thirty patients required mechanical ventilation at home. Few severe complications were observed in patients receiving IMV.
The integrated use of two NIMV techniques is effective in patients with acute exacerbation of CRF. In most cases intubation and tracheostomy were avoided, thus reducing the complication rate of mechanical ventilation.
急性呼吸衰竭(ARF)可采用有创机械通气(IMV)或无创机械通气(NIMV)进行治疗,后者可避免人工气道相关并发症。为评估负压通气(NPV)联合铁肺与无创正压通气(NPPV)的综合治疗方法的疗效,我们对一组因慢性呼吸衰竭(CRF)急性加重而入住我院呼吸重症监护病房(RICU)的患者进行了一项前瞻性研究。
意大利佩鲁贾“R. 西尔维斯特里尼”医院的RICU。
152例连续入选的患者纳入本研究,首选铁肺进行治疗,若有禁忌或不耐受,则使用鼻罩或面罩进行NPPV治疗。无创机械通气(NIMV)2小时后对患者进行重新评估;若临床症状恶化,接受NPV治疗的患者改为NPPV治疗。当NPPV作为一线或二线治疗失败时,对患者进行气管插管。
152例患者接受了NIMV治疗,其中97例首选铁肺治疗,55例首选NPPV治疗。6例接受NPV治疗的患者在治疗的前2小时内改为NPPV治疗。25例患者需要IMV治疗。NIMV(NPV加NPPV)综合使用的成功率为81.6%,NPV的成功率为83.5%,NPPV的成功率为70.5%。21例患者(13.8%)需要气管切开;仅接受NIMV治疗的患者住院时间明显缩短。30例患者需要在家中进行机械通气。接受IMV治疗的患者观察到的严重并发症较少。
两种NIMV技术的综合使用对CRF急性加重患者有效。在大多数情况下避免了气管插管和气管切开,从而降低了机械通气的并发症发生率。